skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Management of chronic anterior uveitis relapses: efficacy of oral phospholipidic curcumin treatment. Long-term follow-up

Original Research

(3160) Views  (977) Full article downloads

Authors: Pia Allegri, Antonio Mastromarino, Piergiorgio Neri

Published Date October 2010 Volume 2010:4 Pages 1201 - 1206
DOI: http://dx.doi.org/10.2147/OPTH.S13271

Pia Allegri1, Antonio Mastromarino1, Piergiorgio Neri2
1Uveitis Center, Ophthalmological Department of Lavagna Hospital, Genova, Italy; 2Uveitis Unit, The Eye Clinic, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Ancona, Italy

Abstract: Curcumin has been successfully applied to treat inflammatory conditions in experimental research and in clinical trials. The purpose of our study is to evaluate the efficacy of an adjunctive-to-traditional treatment with Norflo tablets (curcumin-phosphatidylcholine complex; Meriva) administered twice a day in recurrent anterior uveitis of different etiologies. The study group consisted of 106 patients who completed a 12-month follow-up therapeutic period. We divided the patients into three main groups of different uveitis origin: group 1 (autoimmune uveitis), group 2 (herpetic uveitis), and group 3 (different etiologies of uveitis). The primary end point of our work was the evaluation of relapses frequency in all treated patients, before and after Norflo treatment, followed by the number of relapse in the three etiological groups. Wilcoxon signed-rank test showed a P < 0.001 in all groups. The secondary end points were the evaluation of relapse severity and of the overall quality of life. The results showed that Norflo was well tolerated and could reduce eye discomfort symptoms and signs after a few weeks of treatment in more than 80% of patients. In conclusion, our study is the first to report the potential therapeutic role of curcumin and its efficacy in eye relapsing diseases, such as anterior uveitis, and points out other promising curcumin-related benefits in eye inflammatory and degenerative conditions, such as dry eye, maculopathy, glaucoma, and diabetic retinopathy.

Keywords: curcumin, anterior recurrent uveitis, phosphatidylcholine-bound-curcumin (Meriva)






Readers of this article also read:

Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Enucleation following treatment with intravenous pentamidine for Acanthamoeba sclerokeratitis
Toxicity of antiglaucoma drugs with and without benzalkonium chloride to cultured human corneal endothelial cells
Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility
Editorial
Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
Primary care for diabetes mellitus: perspective from older patients
Erratum